Phibro Animal Health Cash Flow Statement
PAHC / Health Care|14 years of annual SEC 10-K data (FY2012-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 14 fiscal years. All figures from audited SEC 10-K filings.
Phibro Animal Health generated $80M in operating cash flow and $42M in free cash flow in FY2025. Free cash flow margin was 3.2% of revenue.
Based on SEC 10-K filings.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $48.3M | $2.4M | $32.6M | $49.2M | $54.4M | $33.6M | $54.7M | $64.9M | $64.6M | $82.7M | $60.3M | -$3.1M | $24.9M | $7.0M |
| Depreciation & Amortization | $45.6M | $36.2M | $34.0M | $32.7M | $31.9M | $32.3M | $27.6M | $26.9M | $26.0M | $23.5M | $21.6M | $21.5M | $19.0M | $17.5M |
| Operating Cash Flow | $80.1M | $87.6M | $13.3M | $31.6M | $48.3M | $59.3M | $47.2M | $70.0M | $98.4M | $37.2M | $68.7M | -$712.0K | $1.4M | $32.0M |
| Capital Expenditures | $38.3M | $41.2M | $51.8M | $37.0M | $29.3M | $34.0M | $29.9M | $18.5M | $20.9M | $36.4M | $20.1M | $19.8M | $19.9M | $14.8M |
| Free Cash Flow | $41.8M | $46.4M | -$38.5M | -$5.4M | $19.0M | $25.3M | $17.3M | $51.5M | $77.5M | $866.0K | $48.6M | -$20.6M | -$18.5M | $17.2M |
| Dividends Paid | $19.4M | $19.4M | $19.4M | $19.4M | $19.4M | $19.4M | $18.6M | $16.1M | $15.8M | $15.7M | $15.6M | $25.0M | $3.0M | - |
| FCF Margin | 3.2% | 4.6% | -3.9% | -0.6% | 2.3% | 3.2% | 2.1% | 6.3% | 10.1% | 0.1% | 6.5% | -3.0% | -2.8% | 2.6% |